tiprankstipranks
Aligos Therapeutics (ALGS)
NASDAQ:ALGS
US Market
ALGS
Aligos Therapeutics
RESEARCH TOOLSreports
Want to see ALGS full AI Analyst Report?

Aligos Therapeutics (ALGS) Income Statement

297 Followers

Aligos Therapeutics Income Statement

Last quarter (Q4 2025), Aligos Therapeutics's total revenue was $169.00K, a decrease of -73.13% from the same quarter last year. In Q4, Aligos Therapeutics's net income was $-19.88M. See Aligos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.19M$ 3.94M$ 15.53M$ 13.91M$ 4.36M
Gross Profit
$ 1.26M$ 3.94M$ 15.53M$ 13.91M$ 4.36M
Operating Expenses
$ 89.24M$ 93.10M$ 103.66M$ 111.49M$ 132.68M
Depreciation and Amortization
$ 930.00K$ 2.62M$ 3.07M$ 3.67M$ 3.78M
EBITDA
$ -87.06M$ -86.53M$ -85.06M$ -93.91M$ -124.54M
Operating Income
$ -87.98M$ -89.15M$ -88.13M$ -97.58M$ -128.32M
Other Income/Expenses
$ 64.11M$ -41.73M$ 1.24M$ 1.64M$ 132.00K
Pretax Income
$ -23.88M$ -130.88M$ -86.88M$ -95.94M$ -128.19M
Net Income
$ -24.19M$ -131.21M$ -87.68M$ -96.05M$ -128.33M
Per Share Metrics
Basic EPS
$ -2.45$ -20.94$ -3.52$ -2.25$ -3.22
Diluted EPS
$ -2.45$ -20.94$ -3.52$ -2.25$ -3.22
Weighted Average Shares Outstanding
 9.88M 6.26M 24.87M 42.70M 39.86M
Weighted Average Shares Outstanding (Diluted)
 9.88M 6.26M 24.87M 42.70M 39.86M
Currency in USD

Aligos Therapeutics Earnings and Revenue History